CELLECTIS S A's ticker is CLLS and the CUSIP is 15117K103. A total of 32 filers reported holding CELLECTIS S A in Q3 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $601,000 | -16.3% | 262,368 | +3.4% | 0.00% | – |
| Q2 2022 | $718,000 | +32.2% | 253,725 | +112.2% | 0.00% | – |
| Q1 2022 | $543,000 | -42.0% | 119,561 | +3.7% | 0.00% | – |
| Q4 2021 | $936,000 | +277.4% | 115,264 | +486.8% | 0.00% | – |
| Q3 2021 | $248,000 | -16.8% | 19,643 | +2.1% | 0.00% | – |
| Q2 2021 | $298,000 | -61.0% | 19,235 | -49.1% | 0.00% | – |
| Q1 2021 | $764,000 | -28.8% | 37,803 | -4.6% | 0.00% | – |
| Q4 2020 | $1,073,000 | -4.6% | 39,636 | -34.8% | 0.00% | – |
| Q3 2020 | $1,125,000 | +2.8% | 60,836 | -1.0% | 0.00% | – |
| Q2 2020 | $1,094,000 | – | 61,434 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Long Focus Capital Management, LLC | 4,487,293 | $7,089,923 | 0.25% |
| OPPENHEIMER & CO INC | 121,420 | $191,844 | 0.00% |
| CREDIT SUISSE AG/ | 1,438,255 | $2,272,443 | 0.00% |
| Baillie Gifford | 1,164,009 | $1,839,135 | 0.00% |
| PRINCIPAL FINANCIAL GROUP INC | 656,600 | $1,037,428 | 0.00% |
| Capital International Investors | 1,848,804 | $2,921,110 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 1,095,966 | $1,731,626 | 0.00% |
| EverSource Wealth Advisors, LLC | 13 | $21 | 0.00% |
| Qube Research & Technologies Ltd | 40 | $63 | 0.00% |
| Tower Research Capital LLC (TRC) | 111 | $175 | 0.00% |